These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 22964229)

  • 1. Complement dysregulation and disease: from genes and proteins to diagnostics and drugs.
    de Cordoba SR; Tortajada A; Harris CL; Morgan BP
    Immunobiology; 2012 Nov; 217(11):1034-46. PubMed ID: 22964229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement regulators and inhibitory proteins.
    Zipfel PF; Skerka C
    Nat Rev Immunol; 2009 Oct; 9(10):729-40. PubMed ID: 19730437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of complement in AMD.
    Zipfel PF; Lauer N; Skerka C
    Adv Exp Med Biol; 2010; 703():9-24. PubMed ID: 20711704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor H family proteins and human diseases.
    Józsi M; Zipfel PF
    Trends Immunol; 2008 Aug; 29(8):380-7. PubMed ID: 18602340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome.
    Roumenina LT; Jablonski M; Hue C; Blouin J; Dimitrov JD; Dragon-Durey MA; Cayla M; Fridman WH; Macher MA; Ribes D; Moulonguet L; Rostaing L; Satchell SC; Mathieson PW; Sautes-Fridman C; Loirat C; Regnier CH; Halbwachs-Mecarelli L; Fremeaux-Bacchi V
    Blood; 2009 Sep; 114(13):2837-45. PubMed ID: 19584399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement factor H related proteins (CFHRs).
    Skerka C; Chen Q; Fremeaux-Bacchi V; Roumenina LT
    Mol Immunol; 2013 Dec; 56(3):170-80. PubMed ID: 23830046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement factor H-related hybrid protein deregulates complement in dense deposit disease.
    Chen Q; Wiesener M; Eberhardt HU; Hartmann A; Uzonyi B; Kirschfink M; Amann K; Buettner M; Goodship T; Hugo C; Skerka C; Zipfel PF
    J Clin Invest; 2014 Jan; 124(1):145-55. PubMed ID: 24334459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel C3 mutation causing increased formation of the C3 convertase in familial atypical hemolytic uremic syndrome.
    Sartz L; Olin AI; Kristoffersson AC; Ståhl AL; Johansson ME; Westman K; Fremeaux-Bacchi V; Nilsson-Ekdahl K; Karpman D
    J Immunol; 2012 Feb; 188(4):2030-7. PubMed ID: 22250080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H.
    de Córdoba SR; de Jorge EG
    Clin Exp Immunol; 2008 Jan; 151(1):1-13. PubMed ID: 18081690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of complement in physiology and pathology].
    Klaska I; Nowak JZ
    Postepy Hig Med Dosw (Online); 2007; 61():167-77. PubMed ID: 17410057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The complement fitness factor H: role in human diseases and for immune escape of pathogens, like pneumococci.
    Zipfel PF; Hallström T; Hammerschmidt S; Skerka C
    Vaccine; 2008 Dec; 26 Suppl 8():I67-74. PubMed ID: 19388168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel CFHR1-CFHR5 hybrid leads to a familial dominant C3 glomerulopathy.
    Togarsimalemath SK; Sethi SK; Duggal R; Le Quintrec M; Jha P; Daniel R; Gonnet F; Bansal S; Roumenina LT; Fremeaux-Bacchi V; Kher V; Dragon-Durey MA
    Kidney Int; 2017 Oct; 92(4):876-887. PubMed ID: 28729035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A computational model for the evaluation of complement system regulation under homeostasis, disease, and drug intervention.
    Zewde N; Morikis D
    PLoS One; 2018; 13(6):e0198644. PubMed ID: 29874282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement in glomerular injury.
    Berger SP; Daha MR
    Semin Immunopathol; 2007 Nov; 29(4):375-84. PubMed ID: 17901956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement and glomerular disease: new insights.
    Pickering M; Cook HT
    Curr Opin Nephrol Hypertens; 2011 May; 20(3):271-7. PubMed ID: 21422921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing the Activity of Complement Convertases in Serum/Plasma for Diagnosis of C4NeF-Mediated C3 Glomerulonephritis.
    Blom AM; Corvillo F; Magda M; Stasiłojć G; Nozal P; Pérez-Valdivia MÁ; Cabello-Chaves V; Rodríguez de Córdoba S; López-Trascasa M; Okrój M
    J Clin Immunol; 2016 Jul; 36(5):517-27. PubMed ID: 27146825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The complement system in pediatric systemic lupus erythematosus, atypical hemolytic uremic syndrome, and complocentric membranoglomerulopathies.
    Ornstein BW; Atkinson JP; Densen P
    Curr Opin Rheumatol; 2012 Sep; 24(5):522-9. PubMed ID: 22810363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preface. 15th European Meeting on Complement in Human Disease 2015, Uppsala, Sweden.
    Nilsson B; Ekdahl KN; Kemper C; Mollnes TE
    Mol Immunol; 2015 Sep; 67(1):1-2. PubMed ID: 25934434
    [No Abstract]   [Full Text] [Related]  

  • 19. C5 nephritic factors drive the biological phenotype of C3 glomerulopathies.
    Marinozzi MC; Chauvet S; Le Quintrec M; Mignotet M; Petitprez F; Legendre C; Cailliez M; Deschenes G; Fischbach M; Karras A; Nobili F; Pietrement C; Dragon-Durey MA; Fakhouri F; Roumenina LT; Fremeaux-Bacchi V
    Kidney Int; 2017 Nov; 92(5):1232-1241. PubMed ID: 28712854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN.
    Iatropoulos P; Daina E; Curreri M; Piras R; Valoti E; Mele C; Bresin E; Gamba S; Alberti M; Breno M; Perna A; Bettoni S; Sabadini E; Murer L; Vivarelli M; Noris M; Remuzzi G; ;
    J Am Soc Nephrol; 2018 Jan; 29(1):283-294. PubMed ID: 29030465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.